| Log in

Strides Arcolab promoters may sell their entire stake for $540M, Pfizer front-runner

06 December, 2012

Promoters of Strides Arcolab Ltd, who were earlier involved in negotiations for selling the injectables business of the public listed company, are now also looking to sell their ow ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B

Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B

Sneha Shah 5 years ago
Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides...
Strides Arcolab Mulling Sale Of Generic Pharma To SeQuent

Strides Arcolab Mulling Sale Of Generic Pharma To SeQuent

Boby Kurian 8 years ago
Bangalore-based mid-sized and deal-savvy Strides Arcolab may be exploring the...
Symphony Entity Sells Shares In Strides Arcolabs

Symphony Entity Sells Shares In Strides Arcolabs

Manish Tulsian 8 years ago
Zenith Pharmaceuticals, the single largest shareholder in Bangalore-based drug...
No Comments

Strides Arcolab promoters may sell their entire stake for $540M, Pfizer front-runner

Powered by WordPress.com VIP